LOGIN  |  REGISTER
Amneal Pharmaceuticals
Recursion

The Cigna Group's First Quarter 2023 Earnings Release Details

April 12, 2023 | Last Trade: US$279.32 0.61 -0.22

BLOOMFIELD, Conn., Apr. 12, 2023 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its first quarter 2023 financial results on Friday, May 5, 2023, and will host a conference call the same day.

First quarter 2023 financial results will be released no later than 6:30 a.m. Eastern Time (ET). Management will review these results on a conference call beginning at 8:30 a.m. ET. The call-in numbers are as follows:

               Live Call
               (888) 455-5036 (Domestic)
               (773) 799-3981 (International)
               Passcode: 5052023

               Replay
               (888) 282-0036 (Domestic)
               (203) 369-3022 (International)

It is strongly suggested that participants dial in to the conference call by 8:15 a.m. ET on May 5. A replay of the call will be available from 12:30 p.m. ET on May 5 until 11:59 p.m. ET on May 19, 2023. Additionally, the conference call will be available on a live internet webcast at https://investors.thecignagroup.com/events-and-presentations/default.aspx in the Investor Relations section of The Cigna Group's website. Please note that this feature will be in listen-only mode.

A copy of the company's news release and financial supplement will be available on The Cigna Group's website in the Investor Relations section at https://investors.thecignagroup.com/overview/default.aspx, no later than 6:30 a.m. ET on May 5.

About The Cigna Group

The Cigna Group (NYSE:CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and services marketed under Cigna Healthcare, Evernorth Health Services or its subsidiaries. The Cigna Group maintains sales capabilities in more than 30 countries and jurisdictions, and has approximately 190 million customer relationships around the world. Learn more at thecignagroup.com.

Investor Relations Contact
Ralph Giacobbe
1 (860) 787-7968
This email address is being protected from spambots. You need JavaScript enabled to view it.

Media Contact
Justine Sessions
1 (860) 810-6523
This email address is being protected from spambots. You need JavaScript enabled to view it.

Stock Quote

Featured Stock

Astria Therapeutics

Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...

CLICK TO LEARN MORE

Featured Stock

ClearPoint Neuro

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page